Role of myofibroblasts in tumour encapsulation of hepatocellular carcinoma in haemochromatosis

Liver

Volumn 21, Issue 2, 2001, Pages 96-104

  Bridle, Kim R ^a   Crawford, Darrell H G ^a,b   Powell, Lawrie W ^a   Ramm, Grant A ^a,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Smooth muscle actin; Collagen; Haemochromatosis; Hepatic stellate cells; Hepatocellular carcinoma; Malondialdehyde; Myofibroblasts; PDGF receptor; TGF

Indexed keywords

ALPHA ACTIN; COLLAGEN; IRON; MALONALDEHYDE; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROCOLLAGEN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CANCER REGRESSION; CELL COUNT; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; COMORBIDITY; CONTROLLED STUDY; GENE LOCATION; HEMOCHROMATOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; MALE; MESENCHYME CELL; MYOFIBROBLAST; PHENOTYPE; PORTAL VEIN; PROGNOSIS; PROTEIN EXPRESSION; SMOOTH MUSCLE;

ACTINS; AGED; CARCINOMA, HEPATOCELLULAR; CELL COUNT; FIBROBLASTS; HEMOCHROMATOSIS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER NEOPLASMS; LYSINE; MALE; MALONDIALDEHYDE; MIDDLE AGED; MUSCLE, SMOOTH; PROCOLLAGEN; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0035042301     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2001.021002096.x     Document Type: Article

References (39)

1. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis
2. Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases
3. Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases
4. Clinicopathologic features of encapsulated hepatocellular carcinoma: A study of 26 cases
5. Evidence that "myofibroblast-like" Cells are the cellular source of capsular collagen in hepatocellular carcinoma
6. Iron and neoplasia
7. HNE interacts directly with JNK isoforms in human hepatic stellate cells
8. Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia
9. Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy
10. TGF-beta and collagen-alpha 1 (I) gene expression are increased in hepatic acinar zone 1 of rats with iron overload
11. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein
12. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload
13. Modulation of platelet-derived growth factor receptor expression in microvascular endothelial cells during in vitro angiogenesis
14. Relative platelet-derived growth factor receptor subunit expression determines cell migration to different dimeric forms of PDGF
15. Hepatic stellate (ITO) cells: Expanding roles for a liver-specific pericyte
16. Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis
17. Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology
18. Immunolocalization of matrix metallo-proteinases and their tissue inhibitor in human mammary pathology
19. Evidence for altered hepatic matrix degradation in genetic haemochromatosis
20. Elevated serum type IV collagen: A sensitive indicator of the presence of cirrhosis in haemochromatosis
21. The incidence of cancer among blood donors
22. Roles of iron in neoplasia. Promotion, prevention, and therapy
23. Lung cancer among iron ore miners in east Slovakia: A case-control study
24. International renal-cell cancer study. IV. Occupation
25. Onset of hepatocellular carcinoma in a non-cirrhotic patient affected with haemochromatosis
26. Primary liver cancer in genetic hemochromatosis: A clinical, pathological, and pathogenetic study of 54 cases
27. Iron in cancer
28. Transferrin synthesis by small cell lung cancer cells acts as an autocrine regulator of cellular proliferation
29. Cyclic AMP stimulation of transferrin secretion by breast cancer cell grown on extracellular matrix or in two-compartment culture chambers
30. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression
31. Stimulation of collagen gene expression by ascorbic acid in cultured human fibroblasts. A role for lipid peroxidation?
32. Excess iron induces hepatic oxidative stress and transforming growth factor beta 1 in genetic hemochromatosis
33. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies
34. Elevated levels of transforming growth factor beta messenger RNA and its polypeptide in human hepatocellular carcinoma
35. Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers
36. Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture
37. Pathobiology of hepatic stellate cells
38. Rat liver myofibroblasts and hepatic stellate cells: Different cell populations of the fibroblast lineage with fibrogenic potential
39. Cytokines and cellular crosstalk involved in the activation of fat-storing cells